ONCODESIGN
Develops therapeutic and diagnostic solutions for resistant and metastatic cancers.
ALONC | PA
Overview
Corporate Details
- ISIN(s):
- FR0011766229
- LEI:
- 9695004HPDBVG72O8851
- Country:
- France
- Address:
- 20 RUE JEAN MAZEN, 21000 DIJON
- Website:
- https://www.oncodesign.com/
Description
Oncodesign Precision Medicine is a biotechnology company specializing in precision medicine. Its mission is to develop and deliver innovative therapeutic and diagnostic solutions to treat resistant and metastatic cancers. The company utilizes a unique, patient-centric model and a proprietary technology platform to discover and advance effective treatments. This approach is centered on translational thinking, aiming to address the challenges of therapeutic resistance and metastasis evolution by focusing on unmet patient needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-12-13 14:25 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Autres comm…
|
French | 150.7 KB | ||
| 2022-12-13 11:17 |
Franchissement de seuils
|
French | 209.0 KB | ||
| 2022-11-24 08:00 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 145.1 KB | ||
| 2022-11-23 17:37 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 724.9 KB | ||
| 2022-11-23 17:36 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 2.3 MB | ||
| 2022-11-08 16:38 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 2.2 MB | ||
| 2022-11-08 15:54 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 231.6 KB | ||
| 2022-11-02 17:28 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 1.0 MB | ||
| 2022-11-02 17:25 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 506.0 KB | ||
| 2022-10-26 11:17 |
Franchissement de seuil
|
French | 198.3 KB | ||
| 2022-10-26 11:16 |
Franchissement de seuils
|
French | 206.0 KB | ||
| 2022-10-19 08:00 |
Inside Information / Operations of the issuer (acquisitions, sales...)
|
English | 340.5 KB | ||
| 2022-10-19 08:00 |
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 390.8 KB | ||
| 2022-10-04 18:00 |
Inside Information / Other news releases
|
English | 268.6 KB | ||
| 2022-10-04 18:00 |
Informations privilégiées / Autres communiqués
|
French | 273.9 KB |
Automate Your Workflow. Get a real-time feed of all ONCODESIGN filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ONCODESIGN
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ONCODESIGN via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
